This filing amends an original submitted 2026-05-13, which is not in this dataset. View the filer’s history on EDGAR.
Sale of 4,281 shares at $37.0868 per share.
Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code S
Traded May 12, 2026 · Disclosed Aug 12, 2026FILED +92 DAYS
Source: SEC Form 4 · 0001859453-26-000011 · filed 2026-08-12 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Vera Therapeutics, Inc. (VERA)." Disclosed 2026-08-12. https://desqlong.com/cards/0001859453-26-000011-3 (retrieved 2026-09-26).